Clinical and Experimental Reproductive Medicine

  • 제40권4호
  • /
  • Pages.143-147
  • /
  • 2013
  • /
  • 2233-8233(pISSN)
  • /
  • 2233-8241(eISSN)
대한생식의학회 (The Korean Society for Reproductive Medicine)
권호 표지
DOI QR코드

DOI QR Code

In vitro maturation: Clinical applications

  • 투고 : 2013.10.17
  • 심사 : 2013.11.28
  • 발행 : 2013.12.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Oocyte in vitro maturation (IVM) is an assisted reproductive technology in which oocytes are retrieved from the antral follicles of unstimulated or minimally stimulated ovaries. IVM of human oocytes has emerged as a promising procedure. This new technology has advantages over controlled ovarian stimulation such as reduction of costs, simplicity, and elimination of ovarian hyperstimulation syndrome. By elimination or reduction of gonadotropin stimulation, IVM offers eligible infertile couples a safe and convenient form of treatment, and IVM outcomes are currently comparable in safety and efficacy to those of conventional in vitro fertilization. IVM has been applied mainly in patients with polycystic ovary syndrome or ultrasound-only polycystic ovaries, but with time, the indications for IVM have expanded to other uncommon situations such as fertility preservation, as well as to normal responders. In this review, the current clinical experiences with IVM will be described.

키워드

참고문헌

  1. Trounson A, Wood C, Kausche A. In vitro maturation and the fertilization and developmental competence of oocytes recovered from untreated polycystic ovarian patients. Fertil Steril 1994;62: 353-62.
  2. Cha KY, Chian RC. Maturation in vitro of immature human oocytes for clinical use. Hum Reprod Update 1998;4:103-20. https://doi.org/10.1093/humupd/4.2.103
  3. Edwards RG. Maturation in vitro of human ovarian oocytes. Lancet 1965;2:926-9.
  4. Cha KY, Koo JJ, Ko JJ, Choi DH, Han SY, Yoon TK. Pregnancy after in vitro fertilization of human follicular oocytes collected from nonstimulated cycles, their culture in vitro and their transfer in a donor oocyte program. Fertil Steril 1991;55:109-13. https://doi.org/10.1016/S0015-0282(16)54068-0
  5. Gremeau AS, Andreadis N, Fatum M, Craig J, Turner K, McVeigh E, et al. In vitro maturation or in vitro fertilization for women with polycystic ovaries? A case-control study of 194 treatment cycles. Fertil Steril 2012;98:355-60. https://doi.org/10.1016/j.fertnstert.2012.04.046
  6. Fadini R, Mignini Renzini M, Dal Canto M, Epis A, Crippa M, Caliari I, et al. Oocyte in vitro maturation in normo-ovulatory women. Fertil Steril 2013;99:1162-9. https://doi.org/10.1016/j.fertnstert.2013.01.138
  7. Papanikolaou EG, Platteau P, Albano C, Nogueira D, Cortvrindt R, Devroey P, et al. Immature oocyte in-vitro maturation: clinical aspects. Reprod Biomed Online 2005;10:587-92. https://doi.org/10.1016/S1472-6483(10)61665-3
  8. Son WY, Chung JT, Herrero B, Dean N, Demirtas E, Holzer H, et al.Selection of the optimal day for oocyte retrieval based on the diameter of the dominant follicle in hCG-primed in vitro maturation cycles. Hum Reprod 2008;23:2680-5. https://doi.org/10.1093/humrep/den332
  9. Lim JH, Yang SH, Xu Y, Yoon SH, Chian RC. Selection of patients for natural cycle in vitro fertilization combined with in vitro maturation of immature oocytes. Fertil Steril 2009;91:1050-5. https://doi.org/10.1016/j.fertnstert.2008.01.066
  10. Buckett WM, Chian RC, Dean NL, Sylvestre C, Holzer HE, Tan SL. Pregnancy loss in pregnancies conceived after in vitro oocyte maturation, conventional in vitro fertilization, and intracytoplasmic sperm injection. Fertil Steril 2008;90:546-50. https://doi.org/10.1016/j.fertnstert.2007.06.107
  11. Fadini R, Mignini Renzini M, Guarnieri T, Dal Canto M, De Ponti E, Sutcliffe A, et al. Comparison of the obstetric and perinatal outcomes of children conceived from in vitro or in vivo matured oocytes in in vitro maturation treatments with births from conventional ICSI cycles. Hum Reprod 2012;27:3601-8. https://doi.org/10.1093/humrep/des359
  12. Cha KY, Chung HM, Lee DR, Kwon H, Chung MK, Park LS, et al. Obstetric outcome of patients with polycystic ovary syndrome treated by in vitro maturation and in vitro fertilization-embryo transfer. Fertil Steril 2005;83:1461-5. https://doi.org/10.1016/j.fertnstert.2004.11.044
  13. Nargund G, Waterstone J, Bland J, Philips Z, Parsons J, Campbell S. Cumulative conception and live birth rates in natural (unstimulated) IVF cycles. Hum Reprod 2001;16:259-62. https://doi.org/10.1093/humrep/16.2.259
  14. Chian RC, Chung JT, Downey BR, Tan SL. Maturational and developmental competence of immature oocytes retrieved from bovine ovaries at different phases of folliculogenesis. Reprod Biomed Online 2002;4:127-32. https://doi.org/10.1016/S1472-6483(10)61929-3
  15. Chian RC, Buckett WM, Abdul Jalil AK, Son WY, Sylvestre C, Rao D, et al. Natural-cycle in vitro fertilization combined with in vitro maturation of immature oocytes is a potential approach in infertility treatment. Fertil Steril 2004;82:1675-8. https://doi.org/10.1016/j.fertnstert.2004.04.060
  16. Lim JH, Yang SH, Chian RC. New alternative to infertility treatment for women without ovarian stimulation. Reprod Biomed Online 2007;14:547-9. https://doi.org/10.1016/S1472-6483(10)61042-5
  17. Yang SH, Patrizio P, Yoon SH, Lim JH, Chian RC. Comparison of pregnancy outcomes in natural cycle IVF/M treatment with or without mature oocytes retrieved at time of egg collection. Syst Biol Reprod Med 2012;58:154-9. https://doi.org/10.3109/19396368.2012.655403
  18. Beerendonk CC, van Dop PA, Braat DD, Merkus JM. Ovarian hyperstimulation syndrome: facts and fallacies. Obstet Gynecol Surv 1998;53:439-49. https://doi.org/10.1097/00006254-199807000-00024
  19. Delvigne A, Rozenberg S. Preventive attitude of physicians to avoid OHSS in IVF patients. Hum Reprod 2001;16:2491-5. https://doi.org/10.1093/humrep/16.12.2491
  20. Isik AZ, Vicdan K. Combined approach as an effective method in the prevention of severe ovarian hyperstimulation syndrome. Eur J Obstet Gynecol Reprod Biol 2001;97:208-12. https://doi.org/10.1016/S0301-2115(00)00539-X
  21. Wiener-Megnazi Z, Lahav-Baratz S, Rothschild E, Abramovici H, Dirnfeld M. Impact of cryopreservation and subsequent embryo transfer on the outcome of in vitro fertilization in patients at high risk for ovarian hyperstimulation syndrome. Fertil Steril 2002;78: 201-3. https://doi.org/10.1016/S0015-0282(02)03190-4
  22. Delvigne A, Carlier C, Rozenberg S. Is coasting effective for preventing ovarian hyperstimulation syndrome in patients receiving a gonadotropin-releasing hormone antagonist during an in vitro fertilization cycle? Fertil Steril 2001;76:844-6. https://doi.org/10.1016/S0015-0282(01)02007-6
  23. El-Sheikh MM, Hussein M, Sheikh AA, Fouad S, El-Sheikh R, Al- Hasani S. Limited ovarian stimulation results in the recovery of mature oocytes in polycystic ovarian disease patients: a preliminary report. Eur J Obstet Gynecol Reprod Biol 1999;83:81-3. https://doi.org/10.1016/S0301-2115(98)00259-0
  24. El-Sheikh MM, Hussein M, Fouad S, El-Sheikh R, Bauer O, Al-Hasani S. Limited ovarian stimulation (LOS), prevents the recurrence of severe forms of ovarian hyperstimulation syndrome in polycystic ovarian disease. Eur J Obstet Gynecol Reprod Biol 2001;94: 245-9. https://doi.org/10.1016/S0301-2115(00)00309-2
  25. Lim K, Lee W, Lim J. IVM after interruption of COH for the prevention of OHSS. Fertil Steril 2005;84:S84-S5.
  26. Van Campenhout J, Vauclair R, Maraghi K. Gonadotropin: resistant ovaries in primary amenorrhea. Obstet Gynecol 1972;40:6-12.
  27. Talbert LM, Raj MH, Hammond MG, Greer T. Endocrine and immunologic studies in a patient with resistant ovary syndrome. Fertil Steril 1984;42:741-4. https://doi.org/10.1016/S0015-0282(16)48200-2
  28. Grynberg M, El Hachem H, de Bantel A, Benard J, le Parco S, Fanchin R. In vitro maturation of oocytes: uncommon indications. Fertil Steril 2013;99:1182-8. https://doi.org/10.1016/j.fertnstert.2013.01.090
  29. Chian RC, Uzelac PS, Nargund G. In vitro maturation of human immature oocytes for fertility preservation. Fertil Steril 2013;99: 1173-81. https://doi.org/10.1016/j.fertnstert.2013.01.141
  30. Huang JY, Buckett WM, Gilbert L, Tan SL, Chian RC. Retrieval of immature oocytes followed by in vitro maturation and vitrification: a case report on a new strategy of fertility preservation in women with borderline ovarian malignancy. Gynecol Oncol 2007; 105:542-4. https://doi.org/10.1016/j.ygyno.2007.01.036
  31. Huang JY, Chian RC, Gilbert L, Fleiszer D, Holzer H, Dermitas E, et al. Retrieval of immature oocytes from unstimulated ovaries followed by in vitro maturation and vitrification: a novel strategy of fertility preservation for breast cancer patients. Am J Surg 2010; 200:177-83. https://doi.org/10.1016/j.amjsurg.2009.04.004

피인용 문헌

  1. Noninvasive assays of in vitro matured human oocytes showed insignificant correlation with fertilization and embryo development vol.292, pp.2, 2013, https://doi.org/10.1007/s00404-015-3644-y
  2. In vitro maturation of oocytes is not associated with altered deoxyribonucleic acid methylation patterns in children from in vitro fertilization or intracytoplasmic sperm injection vol.103, pp.3, 2013, https://doi.org/10.1016/j.fertnstert.2014.12.096
  3. Effects of granulocyte-macrophage colony-stimulating factor supplementation in culture medium on embryo quality and pregnancy outcome of women aged over 35 years vol.33, pp.1, 2013, https://doi.org/10.1007/s10815-015-0627-7
  4. Oocyte in vitro maturation: A sytematic review vol.15, pp.2, 2013, https://doi.org/10.4274/tjod.23911
  5. Improvement of oocyte in vitro maturation from mice with polycystic ovary syndrome by human mesenchymal stromal cell–conditioned media vol.119, pp.12, 2013, https://doi.org/10.1002/jcb.27380
  6. The Place of In Vitro Maturation in Assisted Reproductive Technology vol.1, pp.1, 2013, https://doi.org/10.1142/s2661318219300022
  7. In Vitro Oocyte Maturation Rate of Mice with Polycystic Ovarian Syndrome in the Presence of α-Linolenic Acid Antioxidant vol.22, pp.2, 2013, https://doi.org/10.5812/zjrms.95100
  8. The impact of timing for estrogen supplementation in polycystic ovary syndrome patients undergoing primed in vitro maturation vol.47, pp.8, 2013, https://doi.org/10.1111/jog.14858